DNAe
9 FOLLOWERS
Read the latest news from DNAe about Next-generation sequencing. Next-generation sequencing company developing novel diagnostics for use at the point of need. At DNAe, we are leading the way in rapid, near-patient sequencing testing that will revolutionize patient care for a range of unmet clinical needs. We have pioneered the use of semiconductor sequencing to build a simple-to-use diagnostic..
DNAe
4M ago
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, provides a business update on its LiDia-SEQ™ technology platform, and operational activities as the Company accelerates preparation of its commercialization strategy and roadmap ..read more
DNAe
2y ago
DNAe, the next generation sequencing (NGS) company developing novel diagnostics for use at the point-of-need, provides an update on its significant research and development (R&D) and operational achievements in 2019 ..read more
DNAe
2y ago
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, today announces positive results from internal tests using its LiDia-SEQ™ sequencing technology to identify SARS-CoV-2. The SARS-CoV-2 coronavirus is the cause of the COVID-19 pandemic currently causing extensive mortality, morbidity and disruption globally ..read more
DNAe
2y ago
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, today provides an update on its response to the COVID-19 pandemic and announces that internal testing is underway to evaluate use of the LiDia-SEQ™ sequencing technology for the current SARS-CoV-2 pandemic and to help in containing future outbreaks ..read more
DNAe
2y ago
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, has appointed Alison Howie as Vice President of Commercial with immediate effect ..read more
DNAe
2y ago
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, today announced that the US Food and Drug Administration (FDA) has granted it a “Breakthrough Device” designation for its pioneering platform and first assay ..read more
DNAe
2y ago
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, has appointed Richard Hammond as Vice President of Technology ..read more
DNAe
2y ago
DNAe co-founder Professor Christofer Toumazou has been officially announced as a laureate of the 2021 UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences – the first UK winner ..read more
DNAe
2y ago
Together with Imperial College London (‘Imperial’), DNAe has been awarded a UK Knowledge Transfer Partnership (KTP) by Innovate UK to support development of its next generation sequencing (NGS)-based diagnostic platform for use in cancer monitoring ..read more
DNAe
2y ago
DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, has expanded its Commercial team, appointing Supriya Mathur to the newly created role of Global Head of Communications ..read more